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Ethylene glycol is highly toxic and represents an important cause of poisonings worldwide.
Toxicity can result in central nervous system dysfunction, cardiovascular compromise, ele-
vated anion gap metabolic acidosis and acute kidney injury. Many states have passed laws
requiring addition of the bittering agent, denatonium benzoate, to ethylene glycol solutions
to reduce severity of exposures. The objectives of this study were to identify differences
between unintentional and intentional exposures and to evaluate the utility of denatonium
benzoate as a deterrent.
Methods and Findings
Using the National Poison Data System, we performed a retrospective analysis of reported
cases of ethylene glycol exposures from January 2006 to December 2013. Outcome classi-
fication was summed for intentionality and used as a basis for comparison of effect groups.
There were 45,097 cases of ethylene glycol exposures resulting in 154 deaths. Individuals
more likely to experience major effects or death were older, male, and presented with more
severe symptoms requiring higher levels of care. Latitude and season did not correlate with
increased exposures; however, there were more exposures in rural areas. Denatonium
benzoate use appeared to have no effect on exposure severity or number.
Conclusion
Deaths due to ethylene glycol exposure were uncommon; however, there were major clini-
cal effects and more exposures in rural areas. Addition of denatonium benzoate was not
associated with a reduction in exposures. Alternative means to deter ingestion are needed.
These findings suggest the need to consider replacing ethylene glycol with alternative and
less toxic agents.
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Introduction
Ethylene glycol is a synthetic, colorless, and odorless liquid that tastes sweet and is used
primarily to produce plastic containers and polyester fibers and secondarily as the main
component in engine antifreeze [1]. Despite its utility, ethylene glycol is highly toxic and
represents an important and persistent cause of intentional and unintentional poisonings
worldwide [1–5]. Toxicity occurs after enzymatic conversion of the parent alcohol to glycolic
acid and oxalic acid, which both produce numerous clinical manifestations, including confu-
sion, nausea, vomiting, central nervous system dysfunction, cardiovascular compromise, ele-
vated anion gap metabolic acidosis, and acute kidney injury [6–9]. Treatment includes
supportive care, inhibition of alcohol dehydrogenase with intravenous fomepizole [7,10–12],
and renal replacement therapy when there is severe acidemia or end organ injury, including
acute kidney injury or severe neurologic impairment [13]. Prior to approval of fomepizole
by the FDA in 1997 for the treatment of ethylene glycol poisoning [10], ethanol, used to
inhibit alcohol dehydrogenase, was a mainstay of therapy. Ethanol continues to be used
worldwide, but serious adverse side effects, including sedation and hypoglycemia, limit its
utility [14,15].
In an attempt to limit human and animal exposures to ethylene glycol, denatonium benzo-
ate (commonly Bitrex1), the most bitter-tasting compound known to man, has been added to
ethylene glycol in antifreeze to serve as a non-toxic deterrent in many countries, including the
United Kingdom, Canada, and the United States [16,17]. The first law in the United States
requiring its addition was passed in the state of Oregon in 1991 [18,19]. Sixteen other states fol-
lowed suit, yet attempts to pass national legislation mandating addition of bittering agent to
engine coolant and antifreeze have failed [20]. In 2012, the Consumer Specialty Products Asso-
ciation announced an agreement with the Humane Society Legislative Fund to voluntarily add
this agent; however, previous limited state-specific analysis of the utility of denatonium benzo-
ate showed no reduction in exposures [21–24].
We analyzed all cases of reported ethylene glycol exposures within the National Poison
Data System (NPDS) between 2006 and 2013 to determine differences between intentional




The NPDS, maintained by the American Association of Poison Control Centers (AAPCC),
houses case records from the United States Poison Control Network, which receives human
and animal poison exposure reports in all 50 states, the District of Columbia, American Samoa,
the Federated States of Micronesia, Guam, Puerto Rico, and the U.S. Virgin Islands (S1 Table)
[3]. The NPDS is the largest poison-exposure surveillance database in the United States, and is
routinely used by the Centers for Disease Control, Food and Drug Administration, Environ-
mental Protection Agency, Consumer Product Safety Commission and Drug Enforcement
Agency. In 2006, a real-time data-capture repository was established, which replaced and
updated the previous repository. All data analyzed in this report were entered after the new sys-
tem was put into place. The AAPCC reviewed and approved our request for data, and the Insti-
tutional Review Board of Carolinas HealthCare System (CHS) approved this study (CHS IRB
File # 04-14-15EX). Data was anonymized and de-identified prior to analysis. All authors
vouch for the accuracy and completeness of the data.
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Design Overview, Definitions, and Data Analysis
We identified all cases of ethylene glycol exposure in humans within the NPDS from January 1,
2006 to December 31, 2013 using the AAPCC codes for ethylene glycol (automotive products
including antifreeze, generic code 051221) or ethylene glycol (excluding automotive, aircraft,
or boat products, generic code 052160). All cases that were confirmed as non-exposures or
multiple substance exposures and cases outside the United States were excluded from analysis
(S2 Fig). Exposures were classified as intentional, unintentional, other, or unknown. Analysis
included all exposure types unless otherwise noted.
We ascertained the following demographic characteristics from these data: age, weight in
kilograms, date of ingestion, sex, routes of exposure, reason for exposure, clinical effects/com-
plaints, medical interventions, and medical outcomes. Age was calculated using continuous
reported variables except for unintentional ingestions by individuals less than 18 years old,
which includes additional categorical classifications, including:5 years, 6–12 years, teen, and
“unknown child” that were included as discrete age categories. Weight values for children
under two years old were validated to correct for unit errors (pounds instead of kilograms).
This was performed by visualizing weight of all patients under two years old and comparing to
150% of the normal values by age referencing World Health Organization (WHO) growth
charts [25]. Outliers were divided by 2.205 to convert pounds to kilograms (S1 Fig). Seasons
were defined as spring (March 20th to June 20th), summer (June 21st to September 21st), fall
(September 22nd to December 20th), and winter (December 21st to March 19th) as averaged
from 2006 to 2013. The route of exposure was most commonly oral. Other routes of exposure
include ocular, otic, inhalation/nasal, aspiration, parenteral, dermal, rectal, vaginal, and
“unknown.” Cases with a non-oral route of exposure were excluded when measuring the effect
of denatonium benzoate on outcomes. The reason for exposure is coded as “unintentional” (an
unforeseen or unplanned event), “intentional” (the result of a purposeful action), “other”
(malicious as well as contaminant/tampering), “adverse reaction,” or “unknown” (for distribu-
tions see S5 Table). Clinical effects are discrete data fields and coded as “related,” “unknown if
related,” or “not related.” These reflect the assessment of the specialist in the attribution of that
clinical effect to the toxicant in question. There are 131 discrete possible clinical effects associ-
ated with each case; “related” and “unknown if related” were grouped as present, and “not
related” and “not coded/null” as not present.
We report four common clinical complaints (headache, nausea, vomiting and abdominal
pain) and five specific and more serious effects commonly associated with ethylene glycol
ingestion (seizures (single and multiple), seizures (status epilepticus), coma, anion gap acidosis,
and kidney damage). The clinical effect “seizures (single/multiple)” was defined if either “sei-
zures, single” or “seizures, multiple” was coded as present. The clinical effect “anion gap acido-
sis” was defined if either “elevated anion gap” or “metabolic acidosis” was coded as present.
The clinical effect “kidney damage” was defined if any of the following clinical effects were
coded as present: “creatinine elevated,” “oliguria,” “anuria,” and “renal failure.” Effects coded
as “related” and “unknown if related” were summed for each variable. Previous work indicates
that coding of effects can be variable and that it is appropriate to combine similar effects, espe-
cially when there is inherent redundancy in the definition of the clinical effect [26,27]. Data
extracted from the reported therapies include two common interventions for critically ill
patients (intubation and intravenous fluids) and three more specific interventions commonly
recommended and administered to patients who have been exposed to ethylene glycol (etha-
nol, fomepizole, and renal replacement therapy). Therapies coded as “recommended and per-
formed” and “performed” were summed for each variable.
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Medical outcomes are reported by the NPDS using the following five mutually exclusive cat-
egories: no effect (no signs or symptoms due to exposure), minor effect (signs or symptoms
were minimally bothersome and resolved rapidly, e.g., nausea), moderate effect (signs of symp-
toms were more pronounced, prolonged, or systemic in nature but did not require specific
intervention, e.g., acid-base disturbance), major effect (signs or symptoms were life-threatening
or required specific intervention, e.g., seizures), death (death resulting from exposure or a
direct complication of the exposure), unrelated effect (exposure probably not responsible for
the effects), and confirmed non-exposure (exposure later believed to not have occurred). Out-
come classification was summed for intentionality (unintentional or intentional; other reasons
were excluded for this analysis) and used as a basis for separation and comparison of effect
groups. Outcomes were grouped into “minor or no effect,” “death or major effects,” or “moder-
ate effect” for analysis. The contribution to fatality for death cases was requested; cases were
excluded if the AAPCC reviewer did not feel that death was a result of ethylene glycol exposure.
Outcomes were assessed overall, by intentionality, and by ICU use.
Statistical Analyses
Categorical data are reported as summed frequency and percentages and compared using chi-
square or Fisher’s exact tests as indicated. Continuous data are reported as mean and standard
deviation and are compared using a two-tailed unpaired Student’s t-test or an analysis of vari-
ance (ANOVA) as indicated. In the case of a significant ANOVA, we applied the Bonferroni
correction for multiple comparisons of differences between individual groups. We calculated
Pearson correlation coefficients for state incidence proportion compared to population data.
Statistical significance was determined using the Bonferroni correction for multiple compari-
sons (0.05/number of comparison variables) to determine the critical p-value of significance.
Predictors of intentional ethylene glycol exposures and of death were examined using multivar-
iable logistic regression models. Results are reported as odds ratios with 95% confidence inter-
vals and p-values. Odds ratios represent the likelihood that subjects with particular
characteristics intentionally ingested ethylene glycol (or died). Model discrimination was eval-
uated using the concordance statistic (C-statistic), with values ranging from 0 to 1, with those
approaching 1 determining more discriminating models.
Data analysis was performed using Excel (Microsoft Excel for Mac 2011) and R (R Project
for Statistical Computing, version 3.0.2, www.r-project.org) with plyr package (version 1.8)
[28]. Statistical analyses were performed and graphs were generated using Prism 5.0 (Graph
Pad for Mac OS X). To evaluate geographical trends, choropleth maps were generated using
ArcGIS ArcMap (Esri Software, version 10.1) using Jenks natural breaks classification method
and an Albers projection [29]. GIS files containing state and water feature boundary files were
obtained from the National Historical Geographic Information System (NHGIS) and joined
with data generated from the NPDS to generate maps [30]. Joined files were exported to Adobe
Illustrator CS5 (Adobe) where maps were altered for presentation purposes. Logistic regression
analyses were performed using SAS version 9.2 (SAS Institute).
Results
Characteristics of Individuals Exposed to Ethylene Glycol
We identified 45,097 individuals reported to have been exposed to ethylene glycol in the
United States between 2006 and 2013 (S2 Fig depicts method for case inclusion and S3 Fig
depicts number reported by year). Of these exposures, 7,070 (16%) were intentional, and
38,027 (84%) were unintentional (Table 1). Intentional and unintentional groups were signifi-
cantly different (p<0.02) for all demographic and clinical variables shown except weight
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(adults), the season during which the ingestion occurred, and headache. Table 1 includes
selected features most relevant to toxic alcohol ingestion, but does not include all possible clas-
sifications of signs and symptoms, therapies, or outcomes. Males (n = 33,943, 75%) comprised
the majority of exposed individuals. Deaths (n = 154,<1%) made up a low percentage of
reported clinical outcomes. The following were the most notable enriched characteristics of
the intentional ingestion group: older age (mean 39.4 years versus 30.8, p< 0.001), female
Table 1. Baseline Characteristics of Patients with Ethylene Glycol Poisoning in the United States.
Characteristics Total* Intentional Unintentional P-value†
Number of patients, N (%) 45097 (100) 7070 (16) 38027 (84) —
Age at intoxication 30.5 ± 17.23 9512 39.4 ± 15.0 6360 30.8 ± 17.1 31820 <0.001‡
Age  18 at intoxication 37.4 ± 14.4 32841 40.8 ± 14.2 6015 36.3 ± 14.2 25634 <0.001‡
Weight (kg), age  18 83.2 ± 25.3 7238 81.3 ± 21.9 1318 83.7 ± 26.1 5727 0.002‡
Female 11154 (25) 2094 (30) 8408 (22) <0.001
Oral exposure 32992 (73) 6846 (97) 24746 (65) <0.001
Season at time of intoxication
Spring 11398 (25) 1890 (27) 9508 (25) 0.01
Summer 11467 (25) 1781 (25) 9686 (25.5) —
Fall 11240 (25) 1749 (25) 9491 (25) —
Winter 10992 (25) 1650 (23) 9342 (24.5) —
Reported signs and symptoms
Headache 1238 (3) 150 (2) 1088 (3) <0.001
Nausea 2625 (6) 490 (7) 2135 (6) <0.001
Vomiting 2437 (5) 872 (12) 1565 (4) <0.001
Abdominal pain 897 (2) 308 (4) 589 (2) <0.001
Seizure (single/multiple) 184 (<1) 172 (2) 12 (<1) <0.001
Seizure (status) 22 (<1) 20 (<1) 2 (<1) <0.001
Coma 716 (2) 679 (10) 37 (<1) <0.001
Anion gap acidosis 2723 (6) 2491 (35) 232 (<1) <0.001
Kidney damage 1516 (3) 1396 (20) 120 (<1) <0.001
Therapies
Intravenous fluids 4179 (10) 3243 (46) 936 (3) <0.001
Ethanol 524 (1) 377 (5) 147 (<1) <0.001
Fomepizole 4859 (11) 3858 (55) 1001 (3) <0.001
Admitted to ICU 4193 (9) 3593 (51) 600 (2) <0.001
Intubation 1210 (3) 1143 (16) 67 (<1) <0.001
Renal replacement therapy 2456 (5) 2294 (32) 162 (<1) <0.001
Outcomes
Death 154 (<1) 144 (2) 10 (<1) <0.001
Major effect 1672 (4) 1541 (22) 131 (<1) <0.001
Moderate effect 3560 (8) 1654 (23) 1906 (5) <0.001
Minor effect 7379 (16) 806 (11) 6573 (17) <0.001
Plus-minus values are mean (SD) and number of patients reporting
*Total is intentional plus unintentional ingestions
† P-Value compares intentional versus unintentional intoxication, Chi-square test unless otherwise noted, Bonferroni-corrected p-value for significance is
<0.002 (0.05/28 comparison variables)
‡ P-value calculated using a Student’s unpaired two-tailed t-test
doi:10.1371/journal.pone.0143044.t001
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gender (30% versus 22%, p<0.001), kidney damage (20% versus <1%, p<0.001), fomepizole
use (55% versus 3%, p<0.001), and need for renal replacement therapy (32% versus <1%, p
<0.001). Outcomes were also worse for the intentional exposure group, with a higher fre-
quency of major effects (22% versus <1%, p<0.001) and death (2% versus <1%, p<0.001).
Effects and Outcomes of Individuals Exposed to Ethylene Glycol
We compared characteristics of exposed individuals based on clinical severity of exposure and
found significant differences for all comparisons. Overall, 21,895 poisoned individuals were fol-
lowed to three categories of known outcome: minor or no effects (N = 16,155), moderate effects
(N = 3714), and major effects or death (N = 2026, groups compared in Table 2). Individuals
who died or sustained major effects were older (44 years) compared to those with no or only
minor effects (29.8 years), and more often male (72% versus 77%) and exposed intentionally
(93% versus 13%).
Table 2. Characteristics of PatientsWho Experienced Effects Attributed to Ethylene Glycol Poisoning*.
Characteristics Minor and no effects Moderate effects Death and major effects
Number of patients, N (%) 16155 3714 2026
Age at intoxication† 29.8 ± 17.5 14421 37.8 ± 15.2 3476 44.0 ± 15.0 1983
Age  18 at intoxication† 36.3 ± 14.3 11135 39.3 ± 14.2 3275 44.9 ± 14.3 1929
Weight (kg), age  18‡ 82.0 ± 27.0 2994 80.9 ± 21.6 670 80.2 ± 21.9 424
Female§ 3720 (23) 1003 (27) 576 (28)
Oral exposure§ 11538 (71) 2383 (64) 1938 (96)
Unintentional§ 14009 (87) 1910 (52) 144 (7)
Unintentional, age < 18§ 3149 (20) 140 (4) 49 (2)
Reported signs and symptoms
Headache 497 (3) 153 (4) 46 (2)
Nausea 1205 (8) 303 (8) 182 (9)
Vomiting 1041 (6) 382 (10) 344 (17)
Abdominal pain 396 (3) 153 (4) 95 (5)
Seizure (single/multiple) 4 (<1) 16 (<1) 192 (10)
Seizure (status) 0 (0) 2 (<1) 22 (1)
Coma 3 (<1) 123 (3) 664 (33)
Anion gap acidosis 43 (<1) 1234 (33) 1614 (80)
Kidney damage 14 (<1) 361 (10) 1246 (61)
Therapies
Intravenous fluids 1268 (8) 1361 (37) 1452 (72)
Ethanol 176 (1) 156 (4) 151(8)
Fomepizole 1517 (9) 1624 (44) 1614 (80)
Admitted to ICU 918 (6) 1493 (40) 1712 (85)
Intubation 16 (<1) 261 (7) 1007 (50)
Renal replacement therapy 164 (1) 847 (23) 1534 (76)
Plus-minus values are mean (SD) with number of patients reporting. Bonferroni-corrected p-value for significance is <0.002 (0.05/19 comparison
variables).
* Includes all classifications of intention, see methods
† P-value calculated using Chi-square, p<0.001 for both age rows, compared by effects
‡ P-value calculated using Chi-square, p = 0.290 for weight, compared by effects
§ P-value calculated using ANOVA comparing three column effect variables is p<0.0001 for all row, variables shown
doi:10.1371/journal.pone.0143044.t002
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Corresponding to the definitions of a major effect from exposure, those in this group were
more likely to suffer kidney damage (n = 1246, 61%), be admitted to the ICU (n = 1712, 85%),
and undergo intubation (n = 1007, 50%) and renal replacement therapy (n = 1534, 76%). Anal-
ysis of therapeutic interventions between 2006 and 2013 revealed stable rates of intravenous
fluid and fomepizole use, but a significant decrease in the requirement for renal replacement
and ethanol therapies (S4A and S4B Fig). During this period, there was also a decrease in the
number of deaths and major effects (S4C and S4D Fig).
Multivariable analysis revealed the following statistically significant predictors of intentional
ethylene glycol exposure: age over 18 years, female gender, oral route of exposure, and spring
compared to fall (Fig 1A, numerical data in S4 Table). Specifically with regards to gender, more
men were exposed to ethylene glycol overall and more men intentionally ingested ethylene gly-
col; however, this analysis implies that women exposed to ethylene glycol are more likely to
experience more serious effects. The risk of intentional ingestion for winter and summer fell
between spring and fall and were not statistically distinct from either. Statistically significant
predictors of major effect(s) and/or death were also identified: age 30 years and higher, spring
compared to fall, and intentionality (Fig 1B). The risks of major effect(s) and/or death in winter
and summer were similar to those in spring. These findings were identical when analyzing pre-
dictors of major effect(s) or death separately (data not shown). Model discrimination was
strong in both models (intentional ingestion C-statistic = 0.74, major effect(s) and/or death C-
statistic = 0.92).
Geographic Trends of Ethylene Glycol Exposures
Choropleth maps depicting frequency of ingestion by population density are shown in the
United States and the District of Columbia and based on intentionality, major outcomes and
deaths combined, and in the pediatric population (age<18) (Fig 2). We compared population
density to the first four variables and the percent of population under the age of 18 for pediatric
ingestions. There was a strong negative correlation between ethylene glycol exposures and pop-
ulation density by state for total, unintentional, and intentional ingestions. There was no corre-
lation between population density and the incidence of major effects or death, or the frequency
of unintentional ingestions in the pediatric population. We found no difference with regard to
exposures by latitude. Alaska had the highest number of intentional and unintentional inges-
tions (S2 Table for rankings). Hawaii had the lowest number of intentional ingestions and Flor-
ida had the lowest number of unintentional ingestions.
Effect of the Aversive Additive Denatonium Benzoate on Oral Ethylene
Glycol Ingestion
Seventeen states now require addition of the bittering agent, denatonium benzoate, to ethylene
glycol preparations as a means to deter individuals from ethylene glycol ingestion (S3 Table).
Limiting our analysis to include only oral exposures, we found no significant difference when
examining intentional and pediatric ingestions by year (Fig 3A and 3B). We examined the
effect of this additive on oral ethylene glycol ingestions in states requiring addition of denato-
nium benzoate, as compared to states not requiring its addition, and found no significant dif-
ference in the total number of ingestions (p = 0.39), unintentional ingestions (p = 0.84), or
pediatric ingestions (p = 0.151) (Fig 3C, 3D and 3F). In fact, there was a significant increase in
the number of intentional ingestions in states with an enacted law (p = 0.034) (Fig 3E). Further-
more, there were no significant differences in deaths or major effects (Fig 3G and 3H).
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Discussion
This analysis of all reported ethylene glycol exposures within the United States over the past
eight years reveals characteristics that differentiate individuals with intentional or uninten-
tional exposures. Those who intentionally exposed themselves to ethylene glycol were more
Fig 1. Logistic regression analysis of risk factors associated with ethylene glycol ingestion. Age is reported in years and each group is compared to
age 18 years. Oral ingestion is compared to all known types of other exposures (unknowns excluded). Listed seasons are compared to Fall. Bonferroni-
corrected p-value <0.003 (0.05/17 or 18 comparison variables) is considered significant. (A) Multivariate model of variables associated with intentional
ingestion (C-statistic = 0.74). (B) Multivariate model of variables associated with major effect(s) and/or death (C-statistic = 0.92). See S4 Table for additional
information.
doi:10.1371/journal.pone.0143044.g001
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Fig 2. Incidence proportion of ethylene glycol exposures and population correlations.Choropleth maps
show incidence proportion for ethylene glycol exposures for (A) all, (B) intentional, (C) unintentional, (D) major
effects and death and (E) pediatric unintentional exposures ( 6 years old). Panels F-J show corresponding
state incidence proportions correlated with population density (population per square mile) by state (F-H),
panel J shows incidence of pediatric unintentional exposures correlated to percent of population of children
under 18 years old by state. Incidence is per 100 000 humans, r = Pearson’s correlation coefficient.
doi:10.1371/journal.pone.0143044.g002
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Fig 3. The effect of addition of bittering agent to ethylene glycol on frequency of oral ingestions in the United States and the District of Columbia.
Panels A and B show incidence of intentional (> 11 years old) and pediatric unintentional oral ingestions ( 6 years old) per year for all states. In 2012,
bitterant was added to commercially sold antifreeze in the United States and the District of Columbia. Panels C-F show no reduction in total, unintentional,
intentional (> 11 years old), or pediatric unintentional oral ingestions ( 6 years old) of ethylene glycol in states that have added bitterant to ethylene glycol
(n = 17) compared to those that have not (n = 34) from 2006–2013. Panels G and H show no reduction in death or major effects in states that have added
bitterant compared to those that have not from 2006–2013. Y-axis represents frequency per 100,000 (100 K) humans for all panels; error is SEM; p-values
calculated using analysis of variance for panels A and B.
doi:10.1371/journal.pone.0143044.g003
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likely to be older, male, and to have more severe signs and symptoms at presentation that
required more intensive therapy. Although deaths and major effects were uncommon and have
been decreasing since 2006 [31], individuals who died and/or experienced major effects,
regardless of intent, have more severe signs and symptoms and were more likely to require
aggressive care. Multivariable analysis confirmed older age and female gender as predictors of
intentionality as well as oral route of exposure; that is, for all individuals exposed to ethylene
glycol, women were more likely to have been exposed intentionally, and those who ingested
ethylene glycol orally were more likely to have done so intentionally. Deaths, major effects, and
moderate effects were also more common in this group. Significant predictors of major effects
and death included older age and intentionality. As previously reported, we confirmed that
fomepizole use has supplanted ethanol as an antidote for ethylene glycol poisoning. This find-
ing corroborates prior studies showing the benefit of fomepizole over ethanol [7,10].
Contrary to our expectations, cases of ethylene glycol exposure were not associated with
northerly latitude or season. Another unexpected finding not shown previously was the associ-
ation of cases of intentional and/or unintentional exposures with low population density; that
is, states with low population density had more reported exposures per capita. This pattern has
not been seen in other types of poisonings in the United States; however, there are low popula-
tion density associations with other types of injuries. For example, a retrospective study
recently reported that Americans in rural regions were more likely to die from unintentional
firearm injuries than those in urban regions [32]. Additionally, suicide rates of rural youth are
nearly double those of urban youth [33]. States with lower population density may have a
greater need for vehicular use, which would suggest increased exposure to ethylene glycol.
Those who live in areas of low population density may be more likely to service their own vehi-
cle. This suggests that resources aimed at decreasing exposures should be targeted to rural
areas.
Limited data exist regarding characteristics of individuals exposed to ethylene glycol and
predictors of poor outcomes [34]. Analysis of California data revealed an association of more
severe clinical signs with individuals exposed to ethylene glycol between 1999 and 2008 who
died or had prolonged renal insufficiency. Improved outcomes were seen with earlier antidote
administration [35]. The degrees of osmolal and anion gaps have also been associated with
increased mortality [2]. More recently, analysis of NPDS data between 2000 and 2013 revealed
that fomepizole use has essentially replaced ethanol as a treatment modality and that the use of
renal replacement therapy is trending down [31]. Our analysis confirms these findings on a
national level and provides additional insight into the link between intention and case
outcome.
Most importantly, we found no change in the number of oral ingestions in states that have
required addition of denatonium benzoate to ethylene glycol preparations. In fact, the number
of intentional exposures has significantly increased. This suggests that the addition of an aver-
sive agent to ethylene glycol may not reduce harm to those who are most affected—individuals
who attempt to commit suicide by ethylene glycol ingestion—as was previously shown in two
states [24]. One of the first commercial uses of denatonium benzoate was as an aversive bitter-
ing agent in a Danish pig farming community where it was applied to pigs’ tails to avoid canni-
balization [36]. Studies have shown that small concentrations of denatonium benzoate were
effective in reducing the volume of material swallowed by children [37]; subsequent studies
have supported this finding [38–40]. It is unclear if addition of denatonium benzoate would
prevent or lessen ethylene glycol poisoning, given that small volumes of ethylene glycol are
toxic; however, denatonium benzoate may be effective in reducing severity rather than fre-
quency of exposure by reducing the volume ingested, which requires future investigation. One
could hypothesize that individuals who intentionally ingest ethylene glycol may be more likely
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to ingest large quantities regardless of bitterness given the intention to inflict self-harm. Single
state studies reinforce our conclusions by demonstrating that addition of denatonium benzoate
to ethylene glycol in Oregon and California did not affect rates of ethylene glycol poisoning in
animals and humans [22–24]. These findings differ from those seen with legislation to prevent
other types of fatalities. For example, more firearm laws are associated with fewer firearm-
related fatalities in the United States [41].
One limitation of this study relates to NPDS data in general [42]. Case records reflect infor-
mation provided when the public or healthcare professionals report an actual or potential
exposure to a substance. Exposures do not necessarily represent a poisoning or overdose [43].
The AAPCC is not able to verify the accuracy of every report made to centers. There is also het-
erogeneity of coding practices across poison centers. Certain infrequent clinical effects are
potentially coded less often than those with greater familiarity, but efforts were made to limit
under-coding by combining related clinical effects to capture more severe effects. This con-
founder is likely similar across all centers and therefore, would not affect conclusions drawn
here. Case outcomes can also be erroneously up-coded in severity, which could potentially
result in greater reported severity of all cases, but comparison between intention and state inci-
dence across time should not be affected. In addition, some fatalities could have been missed in
individuals who died outside of a medical setting. Future efforts to identify such individuals are
needed and could include analysis of state medical examiner death records. Additionally, pro-
spective and longitudinal collection of clinical data from patients with ethylene glycol poison-
ing across major medical centers is warranted to validate and increase granularity of findings
presented here.
Since its discovery by Charles-Adolphe Wurtz in 1856 [44], ethylene glycol has become a
major commercial commodity. The ethylene glycol industry exceeds $21 billion in annual mar-
ket value [45], and demand is increasing. In 2013, 86% of worldwide consumption of mono-
ethylene glycol went into the production of polyethylene terephthalate (PET) (fibers, film and
bottles), and 7.5% was used to produce antifreeze [46]. Alternative means to deter intentional
and unintentional consumption are needed. For example, improved labeling and mandatory
use of child-proof caps are effective in deterring consumption of toxic agents, at least in chil-
dren [47]. Our findings suggest replacing ethylene glycol as a main component in antifreeze
with alternative and less toxic agents with similar properties, such as propylene glycol or glyc-
erol [48], as the morbidity associated with this product is significant, approved alternatives
exist, and deterrents are, in our analysis, ineffective. This study is the first to provide an in-
depth analysis of demographic, clinical, and therapeutic data related to trends in ethylene gly-
col exposures in the United States, and suggests the need to identify and implement more effec-
tive preventative strategies to reduce ethylene glycol poisoning.
Supporting Information
S1 Fig. Determination of weight of all ethylene glycol-exposed individuals under two years
of age.Weight values for children under two years of age were validated to correct for unit
errors (pounds instead of kilograms) that occurred during data entry. This was performed by
visualizing weight of all patients under two years of age and comparing the values to 150% of
the normal values by age (WHO growth charts for reference). Panel A shows two lines fit to
the data using growth chart data. Panel B shows the data after the outliers were divided by
2.205 to convert pounds to kilograms with the assumption that outliers were incorrectly
entered in pounds instead of kilograms.
(TIF)
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S2 Fig. Flow chart of study subject selection.
(PDF)
S3 Fig. Incidents of ethylene glycol exposures from 2006–2013. Number of intentional,
unintentional and other (defined as “malicious,” “contamination,” “tampering,” “adverse
reaction,” and “unknown”) exposures in the United States and District of Columbia
plotted by year. There were no statistically significant differences across the inclusion
period.
(PDF)
S4 Fig. Trends in therapies and outcomes after ethylene glycol exposure. Panels A and B
show trends in use of therapies. Use of intravenous fluid and fomepizole have remained con-
stant while use of renal replacement therapy and ethanol has declined. Panels C and D show
trends in deaths and major effects. X-axis is years and Y-axis is number of times therapy or out-
come was reported in year x per cases reported in year x.
(TIF)
S1 Table. Poison Control Centers within the United States Poison Control Network.
(PDF)
S2 Table. Rank of Top 20 States Based on Number of Intentional or Unintentional Inges-
tions during the Study Period.
(PDF)
S3 Table. Years that States Required Addition of Denatonium Benzoate to Ethylene Glycol
Based Antifreeze Formulations.
(PDF)
S4 Table. Statistics from Logistic Regression Analysis of Risk Factors Associated with Eth-
ylene Glycol Ingestion (Fig 1).
(DOCX)
S5 Table. Reported Reason of Exposure to Ethylene Glycol.
(DOCX)
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